How to buy AstraZeneca shares in 2025

AstraZeneca ($AZN) is a global biopharmaceutical company focused on the discovery, development and commercialisation of prescription medicines for oncology, cardiovascular and respiratory diseases.

👉 Read on to learn about AstraZeneca and how to buy $AZN shares in a few easy steps.

Stock cards hero
A

AZN

A

AZN

A

AZN

A

AZN

A

AZN

A

AZN

A

AZN

A

AZN

A

AZN

A

AZN

How to buy AstraZeneca stock in 5 steps

When investing in shares - whether AZN or otherwise - it’s important to consider your financial position, investing goals and risk tolerance. Before making any investment decision, it’s wise to consider your current circumstances and consult with a financial planner or advisor. If you decide that investing in AstraZeneca is right for you, then consider the following steps.

1. Open an investing account

To buy AstraZeneca stock in Australia, you’ll need to sign up to an investing platform with access to the U.S. share market. Stake offers seamless access to 12,000+ stocks and ETFs across the U.S. and Australian markets, including AZN.

2. Fund your account

Once you’ve opened an account, you’ll need to deposit funds to allow you to buy AZN shares. With Stake, you can deposit via bank transfer, debit/credit card, Apple Pay, Google Pay or set up a recurring deposit using PayTo.

Sign up to invest in AZN stock

Open an account
Stake app pictured on tilted phone screen
3. Search for AstraZeneca or AZN

Find your prospective investment by searching the name or ticker symbol of the company. If you’re using Stake, you can easily search on our web trading platform or the Stake app.

4. Place an order for AZN shares

The next step is to place an order for the number of AstraZeneca shares you’d like to buy. Be sure to check the market is open and ensure the order type and volume align with your investment plan.

5. Monitor your investment

Once your order executes, you should keep an eye on the company’s performance and monitor the performance of your portfolio. Check regularly to ensure your investment is aligned with your financial goals.

Put it on repeat?

If you intend to regularly purchase AZN shares, you could consider setting up a recurring investment. On Stake, you can set up a consistent purchase order for AstraZeneca shares which may be useful if you’re thinking of investing in the company over the long term.


AstraZeneca company overview

AstraZeneca is one of the world’s leading biopharmaceutical companies developing innovative medicines for the treatment of complex diseases. Founded in 1999 through the merger of Astra AB and Zeneca Group, the company has a strong focus on research and development (R&D) in key therapeutic areas including oncology, cardiovascular, renal and metabolism (CVRM) and respiratory diseases. AstraZeneca’s portfolio includes drugs for cancer treatment, diabetes, asthma and other chronic conditions, as well as vaccines, like its COVID-19 vaccine developed in collaboration with Oxford University.


AstraZeneca share price performance

The AstraZeneca share price was US$71.79 (-1.89%) as of market close.

Key metrics for AstraZeneca

Get a breakdown of AstraZeneca’s financial metrics.

Latest market closeUS$71.79
Market capitalisationUS$223.01B
PE Ratio28.85
Earnings per shareUS$2.49
Day change-1.89%
52-week highUS$87.67
52-week lowUS$61.24

Data updated as of May 2, 2025.

Schedule a recurring investment in AstraZeneca

Put your favourites on repeat - like AstraZeneca - with a recurring investment on Stake. It’s a great way to build towards long-term goals and a convenient method to stay consistent with your investing habits.
You’re always in control, it’s easy to hit pause or skip a scheduled order.

Set up a recurring $AZN investment
Recurring investment image

Does AstraZeneca pay dividends?

Yes, AstraZeneca pays dividends.

Dividend yield2.16%

Data updated as of May 2, 2025.

Dividend up arrow

How to sell AstraZeneca shares?

The process of selling AstraZeneca shares on Stake is similar to purchasing them. If you already own AZN shares on the platform and looking to sell, follow these steps:

  1. Open Stake, head to your Holdings and find AstraZeneca
  2. Select Sell
  3. Choose the order type, number of shares/dollar value and the desired price (if applicable)
  4. Review your Sell order
  5. Follow the prompts to submit your order

Watch this video to see just how simple it is to buy and sell shares on Stake.

Is it a good time to buy AstraZeneca shares?

Like any investment, AstraZeneca may be a suitable option for some, but not for others. It’s important to understand that investing in any financial instrument comes with a certain level of risk.

You should always conduct your own research and consider your personal financial circumstances before buying $AZN shares. When researching, consider the company’s financial health, future prospects, current market conditions and whether or not it aligns with your investment strategy.

What are some similar stocks to AZN?

Pfizer Inc. ($PFE): Pfizer is a global pharmaceutical giant engaged in the discovery, development and manufacturing of medicines and vaccines, including prominent drugs in oncology, immunology and cardiovascular health, making it a key peer to AstraZeneca. Bristol Myers Squibb Co. ($BMY): Bristol Myers Squibb is a major biopharmaceutical company focused on oncology, cardiovascular diseases and immunology, offering a range of therapies that compete directly with AstraZeneca's product lines. Merck & Co., Inc. ($MRK): Merck is a leading pharmaceutical company with a robust portfolio of drugs and vaccines, particularly in oncology, infectious diseases and cardiovascular health, operating similarly to AstraZeneca in research and development.

What are some ETFs that hold AZN?

iShares Global Healthcare ETF ($IXJ): This ETF tracks the global healthcare sector, with holdings in AstraZeneca and other leading pharmaceutical companies like Pfizer and Johnson & Johnson, providing diversified exposure to global healthcare stocks. Vanguard FTSE All-World ex-US ETF ($VEU): VEU targets non-U.S. companies across developed and emerging markets, including AstraZeneca as one of its prominent holdings, along with other major international firms in various sectors. iShares MSCI ACWI ex U.S. ETF ($ACWX): Focusing on global stocks outside of the U.S., ACWX includes AstraZeneca as a significant holding, offering broad exposure to international equities across different regions and industries.

Why invest on Stake?

Join 500k+ ambitious investors on a powerful yet easy-to-use trading platform.

Invest in AstraZeneca for as little as US$10

Own a slice of the world’s biggest stocks like AstraZeneca, investing as little as US$10.

12,000+ global opportunities

Hold AUD and USD and glide between Aussie and U.S. markets with just a tap.

Simple fees

$3 brokerage on all trades up to $30,000, whether it’s Wall St or the ASX.

Extended Hours on Wall St

An additional 9.5 hours of Wall St access per trading day, so you can react faster.

Open an account

AstraZeneca Common Questions

If you’re new to the investing world, it’s always wise to get educated on the fundamentals of the market. Luckily you can learn all about it free of charge at our learning hub, Stake Academy. If you decide that AstraZeneca aligns with your financial goals, then follow these steps:
  1. Sign up to Stake on desktop or via the Stake app
  2. Activate Stake wall-st
  3. Deposit funds via bank transfer, credit/debit card, Apple Pay/Google Pay or PayTo
  4. Place a buy order for AstraZeneca
  5. Monitor your investment

With Stake Wall St, you can start investing in U.S. companies like AstraZeneca with as little as US$10 thanks to fractional shares.

Fractional shares allow U.S. investors to purchase a portion of a share in lieu of an entire stock. This can be advantageous for some investors who seek to hold a company in their portfolio but don’t want to pay for a full share.

So, in the case of AstraZeneca, you could buy in with as little as US$10 instead of paying for a full share which was valued at US$70.43 at last market close.

Whether or not AstraZeneca is a good buy is dependent on your investing goals, strategy and risk tolerance. It’s essential to conduct thorough research on AstraZeneca and decide whether you believe it to be a sound investment that aligns with your financial goals.

AstraZeneca typically reports earnings on a quarterly basis. For exact dates, it's best to check AstraZeneca's investor relations page for any adjustments to the schedule​.

The CEO of AstraZeneca is Pascal Soriot, who has led the company since October 2012. Under Soriot's leadership, AstraZeneca has focused on driving growth through innovation, strategic partnerships and expansion into new markets, while advancing its R&D pipeline to deliver transformative medicines to patients worldwide.

Stake app download banner

Take control of your financial future

Build your wealth seamlessly with Stake.
Download on the App StoreGet it on Google Play

This is for information purposes only and is not a recommendation to invest in the securities listed. Such information is not intended to constitute financial advice and no agency or advisory relationship is created between you and Stake as a result of having access to or using the Information. This information does not take into account your personal objectives, financial situation or needs. You agree that neither Stake nor any third party provider is responsible for any investment decisions or for any damages or other losses resulting from the use of the Information. As always, do your own research before making any investment decisions and consider seeking advice from a licensed financial adviser. No representation or warranty is made as to the timeliness, reliability, accuracy or completeness of the material and Stake does not accept any responsibility arising from errors in, or omissions from, the data. Past performance is not a reliable indicator of future performance.


Stake logo
Over 7,000 5-star reviews
App Store logoGoogle Play logo

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.

Stakeshop Pty Ltd, trading as Stake, ACN 610 105 505, is an authorised representative (Authorised Representative No. 1241398) of Stakeshop AFSL Pty Ltd (Australian Financial Services Licence no. 548196). Stake SMSF Pty Ltd ACN 648 283 532 (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. For more information about SMSFs, see our SMSF Risks page. The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services GuideTerms & ConditionsPrivacy Policy and Disclaimers before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

Copyright © 2025 Stake. All rights reserved.

This site uses cookies. By using our site you agree to the Stake Privacy Policy.